Arogo Capital Acquisition Corp
Arogo Capital Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to focus on businesses in transportation and technology industries within the electric vehicles technology, smart mobility, or sustainable … Read more
Arogo Capital Acquisition Corp (AOGO) - Total Liabilities
Latest total liabilities as of September 2024: $9.15 Million USD
Based on the latest financial reports, Arogo Capital Acquisition Corp (AOGO) has total liabilities worth $9.15 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Arogo Capital Acquisition Corp - Total Liabilities Trend (2021–2023)
This chart illustrates how Arogo Capital Acquisition Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Arogo Capital Acquisition Corp Competitors by Total Liabilities
The table below lists competitors of Arogo Capital Acquisition Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Great Elm Group Inc
NASDAQ:GEG
|
USA | $75.80 Million |
|
Y-S Electronic Co Ltd
TWO:6418
|
Taiwan | NT$470.19 Million |
|
First Nordic Metals Corp
OTCQB:FNMCF
|
USA | $4.97 Million |
|
Tien Liang BioTech Co., Ltd.
TWO:4127
|
Taiwan | NT$745.23 Million |
|
First Bancshares Inc. (Bellevue OH)
PINK:FIBH
|
USA | $276.91 Million |
|
Groupe CRIT SA
PA:CEN
|
France | €967.94 Million |
|
Medipharm Labs Corp
OTCQX:MEDIF
|
USA | $8.74 Million |
|
Xander International
TWO:6118
|
Taiwan | NT$2.53 Billion |
Liability Composition Analysis (2021–2023)
This chart breaks down Arogo Capital Acquisition Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Arogo Capital Acquisition Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Arogo Capital Acquisition Corp (2021–2023)
The table below shows the annual total liabilities of Arogo Capital Acquisition Corp from 2021 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $7.66 Million | +66.01% |
| 2022-12-31 | $4.61 Million | +22.82% |
| 2021-12-31 | $3.76 Million | -- |